Last reviewed · How we verify

NCT02871596

Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds - a Randomized, Placebo-controlled, Double-blind, Cross-over Study

Completed NA Last updated 21 February 2017
What this trial tests

NA trial testing Placebo in Healthy in 27 participants. Completed in 1 February 2017.

Timeline
1 August 2016
Primary endpoint
1 February 2017
1 February 2017

Quick facts

Lead sponsorPharmanex
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposeother
Enrollment27
Start date1 August 2016
Primary completion1 February 2017
Estimated completion1 February 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Pharmanex

Who can join

Adults 18 to 70, any sex, with Healthy. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The purpose of the study is to determine the effects of both an anthocyanin-rich polyphenol blend and an anthocyanin-rich polyphenol blend combined with a prebiotic blend on fecal microbiota metabolism (assessed by gas chromatograph - mass spectrometry (GC-MS) headspace analysis) and fecal microbiota composition (assessed by next generation sequencing).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Flavonoids

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Pharmanex trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02871596.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing